NO20010532L - Antioxidant antiproliferative composition which includes a carnitine and a carotenoid - Google Patents
Antioxidant antiproliferative composition which includes a carnitine and a carotenoidInfo
- Publication number
- NO20010532L NO20010532L NO20010532A NO20010532A NO20010532L NO 20010532 L NO20010532 L NO 20010532L NO 20010532 A NO20010532 A NO 20010532A NO 20010532 A NO20010532 A NO 20010532A NO 20010532 L NO20010532 L NO 20010532L
- Authority
- NO
- Norway
- Prior art keywords
- carotenoid
- carnitine
- antioxidant
- composition
- dietary supplement
- Prior art date
Links
- 235000021466 carotenoid Nutrition 0.000 title abstract 2
- 150000001747 carotenoids Chemical class 0.000 title abstract 2
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 title 1
- 230000001028 anti-proliverative effect Effects 0.000 title 1
- 239000003963 antioxidant agent Substances 0.000 title 1
- 230000003078 antioxidant effect Effects 0.000 title 1
- 229960004203 carnitine Drugs 0.000 title 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 abstract 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 abstract 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 abstract 1
- UFAHZIUFPNSHSL-MRVPVSSYSA-N O-propanoyl-L-carnitine Chemical compound CCC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C UFAHZIUFPNSHSL-MRVPVSSYSA-N 0.000 abstract 1
- 240000003768 Solanum lycopersicum Species 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000002248 lipoperoxidative effect Effects 0.000 abstract 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 abstract 1
- 229960004999 lycopene Drugs 0.000 abstract 1
- 235000012661 lycopene Nutrition 0.000 abstract 1
- 239000001751 lycopene Substances 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Alternative & Traditional Medicine (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
En sammensetning er vist som innbefatter som kjennetegnende aktive bestanddeler, propionyl L-karnitin og minst ett karotenoid, typisk lykopenet ekstrahert fra tomat for forebygging og/eller terapeutisk behandling av forskjellige forandringer og patologiske tilstander indusert av frie radikaler og av lipoperoksidasjonsfenomener som kan ta form av et kosttilskudd, koststøtte eller av et reelt legemiddel.A composition is shown which includes as a characterizing active ingredient, propionyl L-carnitine and at least one carotenoid, typically the lycopene extracted from tomato for the prevention and / or therapeutic treatment of various changes and pathological conditions induced by free radicals and of lipoperoxidation phenomena which may take the form of a dietary supplement, dietary supplement or a real drug.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1998RM000516A IT1302125B1 (en) | 1998-08-03 | 1998-08-03 | COMPOSITION WITH ANTIOXIDANT AND ANTIPROLIFERATIVE ACTIVITY INCLUDING A CARNITINE AND A CAROTENOID |
| PCT/IT1999/000251 WO2000007581A2 (en) | 1998-08-03 | 1999-07-29 | Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20010532D0 NO20010532D0 (en) | 2001-01-31 |
| NO20010532L true NO20010532L (en) | 2001-03-20 |
Family
ID=11406082
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20010532A NO20010532L (en) | 1998-08-03 | 2001-01-31 | Antioxidant antiproliferative composition which includes a carnitine and a carotenoid |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1102584A2 (en) |
| JP (1) | JP2002522382A (en) |
| KR (1) | KR20010072146A (en) |
| CN (1) | CN1311674A (en) |
| AR (1) | AR021172A1 (en) |
| AU (1) | AU5064199A (en) |
| BR (1) | BR9912703A (en) |
| CA (1) | CA2338035A1 (en) |
| EE (1) | EE200100052A (en) |
| HK (1) | HK1039062A1 (en) |
| HU (1) | HUP0102807A2 (en) |
| IL (1) | IL140797A0 (en) |
| IS (1) | IS5816A (en) |
| IT (1) | IT1302125B1 (en) |
| MA (1) | MA26666A1 (en) |
| NO (1) | NO20010532L (en) |
| PL (1) | PL346161A1 (en) |
| SK (1) | SK1252001A3 (en) |
| TN (1) | TNSN99152A1 (en) |
| TR (1) | TR200100333T2 (en) |
| WO (1) | WO2000007581A2 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2518926T3 (en) | 2000-06-02 | 2014-11-05 | Board Of Regents, The University Of Texas System | Ethylenedicysteine conjugates and a glucose analogue |
| US6923960B2 (en) | 2001-10-03 | 2005-08-02 | Vsl Pharmaceuticals Inc. | Antioxidant combination composition and use thereof |
| KR100523562B1 (en) | 2001-10-29 | 2005-10-25 | 한국과학기술연구원 | Neuroprotective composition comprising an extract from opuntia ficus-indica and compounds isolated therefrom |
| JP4527938B2 (en) * | 2002-07-23 | 2010-08-18 | オルビス株式会社 | Orally administered composition for antioxidant |
| JP4334189B2 (en) * | 2002-07-30 | 2009-09-30 | カゴメ株式会社 | AGE production inhibitor |
| ITRM20020620A1 (en) * | 2002-12-13 | 2004-06-14 | Sigma Tau Ind Farmaceuti | USE OF CARNITINE FOR THE PREVENTION AND / OR TREATMENT OF DISORDERS CAUSED BY ANDROPAUSE. |
| WO2004092153A1 (en) | 2003-04-14 | 2004-10-28 | Nippon Soda Co. Ltd. | Diamine derivative, production process, and antioxidizing drug |
| US9050378B2 (en) | 2003-12-10 | 2015-06-09 | Board Of Regents, The University Of Texas System | N2S2 chelate-targeting ligand conjugates |
| JP2007519678A (en) * | 2004-01-28 | 2007-07-19 | ネステク ソシエテ アノニム | Nutritional composition for improving skin condition and preventing skin diseases |
| US8758723B2 (en) | 2006-04-19 | 2014-06-24 | The Board Of Regents Of The University Of Texas System | Compositions and methods for cellular imaging and therapy |
| US10925977B2 (en) | 2006-10-05 | 2021-02-23 | Ceil>Point, LLC | Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
| RU2619342C1 (en) * | 2016-02-24 | 2017-05-15 | федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный аграрный университет" | Medication for prevention and treatment of free radical pathology in animals |
| CN113491687A (en) * | 2020-04-02 | 2021-10-12 | 常州高新技术产业开发区三维工业技术研究所有限公司 | Detoxifying medicine composition and application thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU518617B2 (en) * | 1977-04-29 | 1981-10-08 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Therapeutic application of acetyl-d, 1-carnitine |
| EP0400547A1 (en) * | 1989-06-02 | 1990-12-05 | Abbott Laboratories | Parenteral nutrition product |
| IT1276225B1 (en) * | 1995-10-17 | 1997-10-27 | Sigma Tau Ind Farmaceuti | PHARMACEUTICAL COMPOSITIONS CONTAINING L-CARNITINE AND ALKANOYL L-CARNITINE IN ASSOCIATION WITH RESVERATROL OR ITS DERIVATIVES USEFUL FOR |
| IT1277953B1 (en) * | 1995-12-21 | 1997-11-12 | Sigma Tau Ind Farmaceuti | PHARMACEUTICAL COMPOSITION CONTAINING L-CARNITINE OR AN ALCANOYL L-CARNITINE AND A 3-OMEGA SERIES POLYUNSATURED ACID USEFUL |
| IT1283967B1 (en) * | 1996-03-29 | 1998-05-07 | Sigma Tau Ind Farmaceuti | USE OF L-CARNITINE OR L-CARNITINE DERIVATIVES AND ANTIOXIDANTS IN THE PREVENTION AND TREATMENT OF PATHOLOGIES ARISING FROM OXIDATIVE DAMAGES |
| US5667791A (en) * | 1996-05-31 | 1997-09-16 | Thione International, Inc. | X-ray induced skin damage protective composition |
| US5895652A (en) * | 1996-07-29 | 1999-04-20 | Longevity Institute International | Method of metabolic adjuvanation and cellular repair |
| JP2001511153A (en) * | 1997-02-04 | 2001-08-07 | ブイ． コスバブ，ジョン | Compositions and methods for prevention and treatment of vascular degenerative diseases |
| IT1291113B1 (en) * | 1997-03-20 | 1998-12-29 | Sigma Tau Ind Farmaceuti | NUTRITIONAL THERAPEUTIC COMPOSITION FOR SUBJECTS WITH DIABETES MELLITUS |
-
1998
- 1998-08-03 IT IT1998RM000516A patent/IT1302125B1/en active IP Right Grant
-
1999
- 1999-07-29 PL PL99346161A patent/PL346161A1/en unknown
- 1999-07-29 EE EEP200100052A patent/EE200100052A/en unknown
- 1999-07-29 TR TR2001/00333T patent/TR200100333T2/en unknown
- 1999-07-29 KR KR1020017001339A patent/KR20010072146A/en not_active Withdrawn
- 1999-07-29 JP JP2000563266A patent/JP2002522382A/en active Pending
- 1999-07-29 AU AU50641/99A patent/AU5064199A/en not_active Abandoned
- 1999-07-29 EP EP99935044A patent/EP1102584A2/en not_active Withdrawn
- 1999-07-29 SK SK125-2001A patent/SK1252001A3/en unknown
- 1999-07-29 CN CN99809268A patent/CN1311674A/en active Pending
- 1999-07-29 IL IL14079799A patent/IL140797A0/en unknown
- 1999-07-29 HK HK02100334.3A patent/HK1039062A1/en unknown
- 1999-07-29 WO PCT/IT1999/000251 patent/WO2000007581A2/en not_active Ceased
- 1999-07-29 CA CA002338035A patent/CA2338035A1/en not_active Abandoned
- 1999-07-29 BR BR9912703-2A patent/BR9912703A/en not_active Application Discontinuation
- 1999-07-29 HU HU0102807A patent/HUP0102807A2/en unknown
- 1999-07-30 TN TNTNSN99152A patent/TNSN99152A1/en unknown
- 1999-08-03 MA MA25710A patent/MA26666A1/en unknown
- 1999-08-03 AR ARP990103863A patent/AR021172A1/en unknown
-
2001
- 2001-01-16 IS IS5816A patent/IS5816A/en unknown
- 2001-01-31 NO NO20010532A patent/NO20010532L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HK1039062A1 (en) | 2002-04-12 |
| EE200100052A (en) | 2002-06-17 |
| CA2338035A1 (en) | 2000-02-17 |
| WO2000007581A2 (en) | 2000-02-17 |
| TR200100333T2 (en) | 2001-07-23 |
| IS5816A (en) | 2001-01-16 |
| KR20010072146A (en) | 2001-07-31 |
| CN1311674A (en) | 2001-09-05 |
| ITRM980516A1 (en) | 2000-02-03 |
| WO2000007581A3 (en) | 2000-05-11 |
| EP1102584A2 (en) | 2001-05-30 |
| MA26666A1 (en) | 2004-12-20 |
| AU5064199A (en) | 2000-02-28 |
| IT1302125B1 (en) | 2000-07-31 |
| NO20010532D0 (en) | 2001-01-31 |
| ITRM980516A0 (en) | 1998-08-03 |
| TNSN99152A1 (en) | 2005-11-10 |
| PL346161A1 (en) | 2002-01-28 |
| JP2002522382A (en) | 2002-07-23 |
| IL140797A0 (en) | 2002-02-10 |
| HUP0102807A2 (en) | 2002-03-28 |
| SK1252001A3 (en) | 2001-08-06 |
| BR9912703A (en) | 2001-05-02 |
| AR021172A1 (en) | 2002-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20010954L (en) | Antioxidant composition including acetyl L-carnitine and <alfa> lipoic acid | |
| NO20010532L (en) | Antioxidant antiproliferative composition which includes a carnitine and a carotenoid | |
| WO1999066913A3 (en) | Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome, comprising propionyl-l-carnitine and genistein | |
| DK0659402T3 (en) | Formulations containing carotenoids and procarotenoids combined with polyphenols to prevent damage due to abnormal free radical production | |
| ATE245978T1 (en) | COMPOSITIONS CONTAINING PROPIONYL-L-CARNITINE AND HYDROXYCITRIC ACID OR PANTOTHENIC ACID | |
| NO20035473D0 (en) | Orally administered dosage forms of GABA analog prodrugs which have reduced toxicity | |
| ATE406893T1 (en) | PHARMACEUTICAL COMPOSITION (KIT) CONTAINING DIHYDROPYRIDINONE COMPOUNDS AND A COMPOUND HAVING IMMUNOMODULATORY (OR ANTI-INFLAMMATORY) ACTION AND USE THEREOF | |
| ES2137628T3 (en) | STYLBENE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| BRPI0417104A (en) | compost, process for the preparation of a compost, fungicidal composition and method for the preventive or curative combating of plant pathogenic fungi | |
| EP1470817A4 (en) | COMPOSITION AND METHOD FOR THE PREVENTION OF CANCER IN HUMAN SUBJECTS | |
| NO20011693L (en) | Combination of carnitines and resveratrol for the prevention or treatment of cerebral and aging disorders | |
| DK0773022T3 (en) | Pharmaceutical composition for the treatment of rhinitis containing sympathomimetics and pantothenol and / or pantothenic acid | |
| DK0951909T3 (en) | Combination composition comprising an L-carnitine or an alkanoyl-L-carnitine, a glycosaminoglycan and / or component thereof | |
| ECSP034518A (en) | NEW RETINOIDS FOR THE EMPHYSEMA TREATMENT | |
| NO20021640L (en) | Composition for the prevention and / or treatment of circulatory diseases comprising derivatives of L-carnitine and extracts of Gingo biloba | |
| BRPI0405445A (en) | Methods for treating skin conditions | |
| BR0009859A (en) | Fungicide compositions for fruit protection, treatment process of treated fruits and fruits | |
| WO2000000183A3 (en) | Antioxidant, cytostatic and sustained energy composition which ameliorates the metabolic utilization of glucose comprising acetyl-l-carnitine and a catechin | |
| ES2134284T3 (en) | PIRIDO-PIRIMIDINDIONAS, PROCEDURE FOR ITS PREPARATION AND ITS USE AS MEDICINES. | |
| TR200101344T2 (en) | Antioxidant composition consisting of propionyl L-carnitine and a flavonoid | |
| NO20011430D0 (en) | Use of organophosphorus compounds for the manufacture of medicaments for the therapeutic and prophylactic treatment of infections, or as a fungicide, bactericide or herbicide for plants | |
| NO20022288L (en) | Composition for the prevention and / or treatment of disorders caused by abnormal lipid metabolism, including propionyl L-carnitine and chitosan | |
| AU2002333535A1 (en) | Treatment of excessive radiation (e.g. sunburn) exposure | |
| BR0316441A (en) | Use of a compound, compound and medicine | |
| SE8602060D0 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING REDUCED GLUTATION |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |